Detalhe da pesquisa
1.
Glioma progression is shaped by genetic evolution and microenvironment interactions.
Cell
; 185(12): 2184-2199.e16, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649412
2.
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Mol Cancer
; 21(1): 132, 2022 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717322
3.
High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer.
Breast Cancer Res
; 22(1): 30, 2020 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188473
4.
Vascular aging in long-term survivors of testicular cancer more than 20 years after treatment with cisplatin-based chemotherapy.
Br J Cancer
; 123(11): 1599-1607, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32921790
5.
Neuroendocrine tumours and their microenvironment.
Cancer Immunol Immunother
; 69(8): 1449-1459, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32270230
6.
Quantitative Profiling of Platelet-Rich Plasma Indole Markers by Direct-Matrix Derivatization Combined with LC-MS/MS in Patients with Neuroendocrine Tumors.
Clin Chem
; 65(11): 1388-1396, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31551315
7.
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
J Neurooncol
; 144(1): 205-210, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273577
8.
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.
Oncologist
; 23(7): 766-e90, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242283
9.
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
Eur J Nucl Med Mol Imaging
; 45(13): 2404-2412, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30032322
10.
Extra-Pulmonary Neuroendocrine Carcinomas: A Population-Based Study in the Netherlands.
Neuroendocrinology
; 107(1): 50-59, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29945149
11.
Self-monitoring physical activity with a smartphone application in cancer patients: a randomized feasibility study (SMART-trial).
Support Care Cancer
; 26(11): 3915-3923, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29785635
12.
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses.
J Neurooncol
; 131(1): 11-20, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27633774
13.
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis.
J Neurooncol
; 135(1): 183-192, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28730289
14.
Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study.
Support Care Cancer
; 25(7): 2075-2083, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28185086
15.
Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor.
Neuroendocrinology
; 103(5): 489-94, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26335390
16.
Corrigendum to "Dopamine and serotonin regulate tumor behavior by affecting angiogenesis" [Drug Resist. Updat. 17 (2014) 96-104].
Drug Resist Updat
; 53: 100717, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741704
17.
Successful oral desensitization and reintroduction in selected glioma patients with procarbazine-mediated hypersensitivity.
Allergy
; 75(11): 2974-2976, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32484932
18.
Dopamine and serotonin regulate tumor behavior by affecting angiogenesis.
Drug Resist Updat
; 17(4-6): 96-104, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25269824
19.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol
; 15(9): 943-53, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25035291
20.
Cancer survivors' experiences of a physical activity program in primary care: a qualitative study.
J Cancer Surviv
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517578